Cargando…
Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice
INTRODUCTION: Vascular dementia (VaD), one of the brain injuries, is difficult to be cured, so it is important to take active neuroprotective treatment after its occurrence. Many studies have shown that apoptosis serves an important role in VaD occurrence; therefore, inhibition of apoptosis may cont...
Autores principales: | Wu, Xiaolin, Liu, Yingjuan, Zhu, Lin, Wang, Yue, Ren, Yuqian, Cheng, Baohe, Ren, Leiming, Ge, Keli, Li, Hongyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297406/ https://www.ncbi.nlm.nih.gov/pubmed/34305399 http://dx.doi.org/10.2147/NDT.S311760 |
Ejemplares similares
-
Cerebroprotein hydrolysate‐I protects senescence‐induced by D‐galactose in PC12 cells and mice
por: Zhu, Lin, et al.
Publicado: (2021) -
The Cerebroprotein Hydrolysate-I Plays a Neuroprotective Effect on Cerebral Ischemic Stroke by Inhibiting MEK/ERK1/2 Signaling Pathway in Rats
por: Ren, Yuqian, et al.
Publicado: (2021) -
Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway
por: Chen, Moxi, et al.
Publicado: (2023) -
Transcriptome Analysis Reveals the Effects of Troxerutin and Cerebroprotein Hydrolysate Injection on Injured Spinal Cords in Rats
por: Wang, Linbang, et al.
Publicado: (2020) -
CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
por: Liu, Zehui, et al.
Publicado: (2019)